We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$240M
Cap. Flow
+$255M
Cap. Flow %
69.4%
Top 10 Hldgs %
25.49%
Holding
710
New
414
Increased
42
Reduced
13
Closed
237

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Healthcare 11.95%
3 Technology 8.6%
4 Industrials 8.02%
5 Energy 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
351
Xenon Pharmaceuticals
XENE
$6.21B
$140K 0.04%
+4,161
New +$158K
CIG icon
352
CEMIG Preferred Shares
CIG
$5.84B
$140K 0.04%
+79,312
New +$147K
CGON icon
353
CG Oncology
CGON
$6.79B
$139K 0.04%
+5,686
New +$160K
CSAN icon
354
Cosan
CSAN
$2.68B
$139K 0.04%
+26,672
New +$140K
APGE icon
355
Apogee Therapeutics
APGE
$10.2B
$138K 0.04%
+3,701
New +$143K
LENZ
356
LENZ Therapeutics
LENZ
$168M
$137K 0.04%
+5,334
New +$131K
DFTX
357
Definium Therapeutics
DFTX
$5.99B
$137K 0.04%
+23,388
New +$168K
KRP icon
358
Kimbell Royalty Partners
KRP
$1.49B
$136K 0.04%
+9,727
New +$147K
KIM icon
359
Kimco Realty
KIM
$16.2B
$136K 0.04%
+6,400
New +$140K
SVRA icon
360
Savara
SVRA
$1.17B
$136K 0.04%
+49,006
New +$135K
PHVS icon
361
Pharvaris
PHVS
$2.43B
$136K 0.04%
+8,636
New +$146K
SANA icon
362
Sana Biotechnology
SANA
$1B
$135K 0.04%
+80,467
New +$225K
RGNX icon
363
Regenxbio
RGNX
$688M
$135K 0.04%
+18,830
New +$140K
NUVL
364
DELISTED
Nuvalent
NUVL
$134K 0.04%
+1,890
New +$148K
NAMS icon
365
NewAmsterdam Pharma
NAMS
$3.34B
$134K 0.04%
+6,543
New +$145K
KRG icon
366
Kite Realty
KRG
$5.29B
$133K 0.04%
+5,967
New +$136K
PBT
367
Permian Basin Royalty Trust
PBT
$1.52B
$133K 0.04%
+13,420
New +$146K
GPRK icon
368
GeoPark
GPRK
$627M
$132K 0.04%
+16,382
New +$147K
UE icon
369
Urban Edge Properties
UE
$2.75B
$132K 0.04%
6,949
-7,051
-50% -$141K
CELC icon
370
Celcuity
CELC
$4.43B
$132K 0.04%
+13,020
New +$147K
CYTK icon
371
Cytokinetics
CYTK
$10.5B
$131K 0.04%
+3,270
New +$150K
REPL icon
372
Replimune Group
REPL
$1.15B
$131K 0.04%
+13,434
New +$166K
CRC icon
373
California Resources
CRC
$4.77B
$130K 0.04%
+2,965
New +$141K
RVMD icon
374
Revolution Medicines
RVMD
$44.4B
$129K 0.04%
+3,652
New +$148K
ACLX
375
DELISTED
Arcellx
ACLX
$129K 0.04%
+1,968
New +$133K

Similar funds

Virtus Investment Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Virtus Investment Advisers held 710 positions worth $368M, up 188% from $128M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Virtus Investment Advisers deployed $255M of net new capital in Q1 2025, opening 414 new positions and adding to 42 existing holdings. Its largest new stake was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Berry Corp, an estimated $666K trimmed.

  • Virtus Investment Advisers's largest Q1 2025 buy was Virtus Newfleet ABS/MBS ETF: 1,321,000 shares worth $32.2M.
  • Virtus Investment Advisers added most to Yum China in Q1 2025, an estimated $1.42M increase.
  • Virtus Investment Advisers's biggest Q1 2025 reduction was Berry Corp, cutting an estimated $666K.
  • Virtus Investment Advisers fully exited ICICI Bank in Q1 2025, selling an estimated $3.75M.
  • Virtus Investment Advisers's ten largest holdings make up 25% of its $368M portfolio in Q1 2025.
  • Virtus Investment Advisers opened 414 new positions and closed 237 in Q1 2025.
  • Virtus Investment Advisers's portfolio value rose 188% quarter-over-quarter to $368M.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.